EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man

J Endocrinol Invest. 2002 Sep;25(8):RC26-8. doi: 10.1007/BF03345096.

Abstract

EP1572 UMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after s.c. administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute i.v. EP1572 administration (1.0 microg/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Binding, Competitive
  • Dose-Response Relationship, Drug
  • Ghrelin
  • Growth Hormone / blood
  • Growth Hormone / metabolism*
  • Human Growth Hormone / blood
  • Human Growth Hormone / metabolism
  • Humans
  • Indoles
  • Male
  • Oligopeptides / administration & dosage
  • Oligopeptides / metabolism
  • Oligopeptides / pharmacokinetics*
  • Peptide Hormones / metabolism
  • Pituitary Gland / metabolism
  • Rats
  • Tryptophan / analogs & derivatives

Substances

  • Ghrelin
  • Indoles
  • Oligopeptides
  • Peptide Hormones
  • hexarelin
  • Human Growth Hormone
  • macimorelin
  • Tryptophan
  • Growth Hormone